Dr. Edward Charles Federman, MD

Dr. Federman practices at East Campus Medical Center - Pre-Op / Post-Op - HOPD in San Diego, California.

Dr. Federman's NPI, 1548369648, was assigned on September 22, 2006. Dr. Federman graduated from SUNY Upstate Medical University in 1982. Dr. Federman holds California license G60283.

Dr. Federman's primary practice is East Campus Medical Center - Pre-Op / Post-Op - HOPD, at 6655 Alvarado Rd, San Diego, CA 92120.

Dr. Federman's primary practice is East Campus Medical Center - Pre-Op / Post-Op - HOPD in San Diego, California. Dr. Federman is also affiliated with Hillcrest Medical Center. Dmand AI also links Dr. Federman to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Federman practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Federman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Federman is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Federman is licensed in California.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Federman treats.

CMS data shows 4,230 Medicare services from Dr. Federman across 19 procedure codes in 2024, for 501 Medicare patients. Medicare paid $155,896 for them.

CMS counts 501 Medicare patients who saw Dr. Federman in 2024. The largest group is 75 to 84, with 206 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Federman's median patient age at 69, with 44% women.

In 2024, Dr. Federman wrote 2,204 Medicare Part D claims for 263 patients. 64% of them were for generic drugs. CMS names the drug for 1,728 of them, across 44 drugs with 11 or more claims each, at $502,449 in total drug cost. In 2023, CMS named 1,268 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 23 out of 100 for Dr. Federman for performance year 2024, reported individually. Dr. Federman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Federman as offering telehealth.

CMS Open Payments shows 396 general payments to Dr. Federman from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. GlaxoSmithKline, LLC. paid the most, $2,802.

Dmand AI lists 2 awards for Dr. Federman.

Dr. Federman graduated from SUNY Upstate Medical University in 1982.

Dr. Federman is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.